Delivery Order SPE2DB20D1109-SPE2DB24FP41V
Award Date
6/28/24
Potential Completion Date
7/1/24
Potential Value
$2.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product AIMOVIG 140 MG/ML AUTOINJECTORML. The contract, valued at $1,883.86, was awarded by the Defense Logistics Agency (DLA) on June 20, 2024, with a completion date of June 21, 2024. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025, to provide a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division involves the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,169.72 firm-fixed-price delivery order was awarded on July 11, 2024 with a completion date of July 12, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of AIMOVIG 70 MG/ML AUTOINJECTORML pharmaceutical products. The $2,567.03 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $2,988.96 for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product. The contract was awarded on June 11, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, and has a completion date of June 12, 2024. This Delivery Order is placed against Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA,...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order worth $10,844.44 for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 3, 2025. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of AIMOVIG 70 MG/ML AUTOINJECTORML, a pharmaceutical product. The $4,067.19 firm fixed price contract was awarded by the Medical Supply Chain division of the Department of Defense. The contract has an ultimate completion date of July 12, 2024 and was awarded on July 11, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML pharmaceutical products. The $1,743.29 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) and has a completion date of March 5, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025. This IDC...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product AIMOVIG 140 MG/ML AUTOINJECTORML. The $2,040.96 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a period of performance through June 28, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML pharmaceutical products to the Defense Logistics Agency (DLA). The firm fixed price contract, valued at $1,382.46, has a completion date of February 29, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML pharmaceutical products. The $2,715.72 Firm Fixed Price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of May 30, 2024. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and...